A phase II, two-part, multiple-dose, dose-finding, single-blind study to investigate the safety and efficacy of ABP-700 for procedural sedation in adult patients undergoing colonoscopy
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs MDCO 700 (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Acronyms VERONA
- Sponsors The Medicines Company
- 16 May 2017 Status changed from recruiting to suspended.
- 27 Feb 2017 Planned End Date changed from 1 Sep 2016 to 1 Jun 2017.
- 27 Feb 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Jun 2017.